These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3041944)

  • 1. Apraclonidine. A one-week dose-response study.
    Jampel HD; Robin AL; Quigley HA; Pollack IP
    Arch Ophthalmol; 1988 Aug; 106(8):1069-73. PubMed ID: 3041944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
    Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited comparison of apraclonidine's dose response in subjects with normal or increased intraocular pressure.
    Abrams DA; Robin AL; Crandall AS; Caldwell DR; Schnitzer DB; Pollack IP; Rader JE; Reaves TA
    Am J Ophthalmol; 1989 Sep; 108(3):230-7. PubMed ID: 2672819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Miller PE; Nelson MJ; Rhaesa SL
    Am J Vet Res; 1996 Jan; 57(1):79-82. PubMed ID: 8720243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine.
    Coleman AL; Robin AL; Pollack IP; Rudikoff MT; Enger C; Mayer PR
    Arch Ophthalmol; 1990 Sep; 108(9):1264-7. PubMed ID: 2205182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.
    Yüksel N; Karabaş L; Altintaş O; Yildirim Y; Cağlar Y
    Ophthalmologica; 2002; 216(1):45-9. PubMed ID: 11901288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of unilateral 1% apraclonidine therapy.
    Robin AL
    Arch Ophthalmol; 1988 Jul; 106(7):912-5. PubMed ID: 3390053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.
    Stewart WC; Laibovitz R; Horwitz B; Stewart RH; Ritch R; Kottler M
    Arch Ophthalmol; 1996 Aug; 114(8):938-42. PubMed ID: 8694728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.
    Stewart WC; Ritch R; Shin DH; Lehmann RP; Shrader CE; van Buskirk EM
    Arch Ophthalmol; 1995 Mar; 113(3):287-92. PubMed ID: 7887841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.
    Morrison JC; Robin AL
    Ophthalmology; 1989 Jan; 96(1):3-7. PubMed ID: 2645550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin DH; Smythe B; Mundorf T; Lehmann RP
    Am J Ophthalmol; 1995 Oct; 120(4):423-32. PubMed ID: 7573299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine.
    Pollack IP; Brown RH; Crandall AS; Robin AL; Stewart RH; White GL
    Arch Ophthalmol; 1988 Jun; 106(6):754-7. PubMed ID: 3369999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium:YAG posterior capsulotomy.
    Pollack IP; Brown RH; Crandall AS; Robin AL; Stewart RH; White GL
    Trans Am Ophthalmol Soc; 1988; 86():461-72. PubMed ID: 2979050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol.
    Sulewski ME; Robin AL; Cummings HL; Arkin LM
    Arch Ophthalmol; 1991 Jun; 109(6):807-9. PubMed ID: 1675049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Nishimoto JH; Chang FW; Tang IH; Kolin T
    J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apraclonidine and clonidine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers.
    Yüksel N; Güler C; Caglar Y; Elibol O
    Int Ophthalmol; 1992 Sep; 16(4-5):337-42. PubMed ID: 1358852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145).
    Gharagozloo NZ; Relf SJ; Brubaker RF
    Ophthalmology; 1988 Sep; 95(9):1217-20. PubMed ID: 3062536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats.
    Miller PE; Rhaesa SL
    Am J Vet Res; 1996 Jan; 57(1):83-6. PubMed ID: 8720244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 1% apraclonidine on intraocular pressure after cataract surgery.
    Sterk CC; Renzenbrink-Bubberman AC; van Best JA
    Ophthalmic Surg Lasers; 1998 Jun; 29(6):472-5. PubMed ID: 9640568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of apraclonidine 1% in preventing intraocular pressure rise following macular hole surgery.
    Sciscio A; Casswell AG
    Br J Ophthalmol; 2001 Feb; 85(2):164-8. PubMed ID: 11159479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.